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ABSTRACT 
Kenche, Harshavardhan. M.S., Biochemistry and Molecular Biology, Wright State 
University, 2008. Validation of a custom-made microarray to study human intestinal 
microflora  
 
Intestinal microflora refers to all the different species of bacteria that reside in the human 
gut and is an important ‘organ’ of the human body because almost all the digestive 
reactions of the host occur in the intestine. The bacteria of the intestine play a key role in 
this process by supplementing the intestine with various enzymes and proteins that are 
required for the digestive process. At the same time, these bacteria were shown to be 
implicated in a variety of gastrointestinal disorders like Irritable Bowel Syndrome, 
Inflammatory Bowel Disorder and Gastrointestinal Cancer, but with the current 
knowledge about the microflora it is difficult to determine which exact species is 
responsible for a particular disease caused. The knowledge about the composition of the 
typical intestinal microflora is very limited, the cause at large being the lack of proper 
culture techniques to isolate and study the microfloral species in artificial media. 
Majority of the species of the microflora are obligate anaerobes and selective culturing 
techniques provide very limited knowledge about the composition of such complex 
microflora. Phylogenetic microarrays are one such approach to study various members of 
the microflora because they contain probes for numerous species of bacteria on a single 
glass slide and are also known to provide robust and high throughput analysis.  
[iv] 
 
ENTREZ nucleotide database was used to compile a list of 16S ribosomal DNA 
(rDNA) sequences of bacterial species isolated from the human intestine and they were 
grouped into various phylo-species. Representative sequences for each phylo-species 
were extracted and the probes on the microarray were designed based on these 
representative sequences. 16 different bacterial species were used for validation 
experiments, which represented bacteria from various groups. The results showed that the 
microarray correctly identified 15 of a total 16 bacterial species. The detection sensitivity 
of the microarray was at least 1pg. As a test, fecal samples from adults and children were 
analyzed by the microarray. Clostridia were the dominant group of the microflora 
followed by Bacteroidetes in both adults and children. The analysis of the fecal samples 
showed clear differences between the microflora composition of adults and children. 
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1. Introduction 
 
1.1 Microflora: Introduction 
All the various groups of bacterial species that inhabit the intestine of humans are 
collectively referred to as microflora. The field of intestinal microecology is as old as 
medical microbiology. Much effort has been devoted towards investigation of the 
indigenous intestinal flora since the beginning of the century and considerable progress 
has been made in characterizing the intestinal microflora, especially in recent years with 
modern methods of molecular biology, but several problems are confronted in defining 
the normal intestinal microflora. The composition of the flora is quite complex, 
particularly in areas where there are higher counts of bacteria such as colon (>10
11 
organisms per gram dry weight). Many of these organisms have fastidious growth 
requirements and they require a very selective medium for. Detailed studies of the bowel 
flora are extremely time-consuming. However, shortcuts lead to significant inaccuracies. 
As the laboratory techniques get improvised, new species continue to be discovered.  
 Savage (1977) has observed that about 90% of the 10
14
 cells associated with 
human body are microorganisms, and that the vast majority of these bacteria reside in the 
large intestine. Direct microscopic estimations of bacterial numbers in the gut contents 
indicate that considerably more cells are present, and that total counts increase by an 
order of magnitude from the proximal end to distal end of the colon. A vast majority of 
the microbes of the intestine are anaerobes but they exhibit varying degrees of tolerance 
to oxygen. Anaerobic bacteria appear to outnumber the aerobic species by a factor of 
about 1000.  
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 Research suggests that the relationship between the gut flora and host is not 
merely commensal, but rather a mutualistic/symbiotic relationship. Though people can 
survive with no gut flora, the latter perform a lot of useful functions like fermentation of 
unused metabolites, inhibition of growth of harmful species, production of vitamins for 
host and production o hormones to direct the host to store fats. However, in some 
conditions, some species are thought to cause disease by causing infection or increasing 
cancer risk for the host. 
 
Normal microflora of the Stomach  
 It is believed that the intraluminal environment of the normal human stomach is 
relatively sterile, with only few counts of organisms. Studies have shown low counts (<= 
10
3
 colonies per milliliter gastric contents) of α-hemolytic streptococci, anaerobic cocci, 
lactobacilli, Staphylococcus epidermis, and Candida albicans (Giannella et al., 1972; 
Franklin and Skoryna, 1966). These counts may represent oral and ingested organisms 
since counts tend to decrease to zero gradually within several hours after eating. 
Giannella et al. (1972) showed that the gastric pH plays a significant role in controlling 
the growth of organisms in the stomach. When a marker organism (Serratia marcescens) 
was introduced into the normal stomach, it was totally eliminated within half hour. 
Patients with hypochlorhydria have higher bacterial counts. Patients who have undergone 
surgical procedures for gastric disorders also show higher bacterial counts in the stomach, 
which suggests the importance of lower gastric pH in maintaining low microbial counts. 
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Normal microflora of the Small Intestine 
 The amount of flora encountered in the small intestine is strictly dependent of the 
location of sampling. The upper small intestine is usually sterile (or has a low microbial 
count) when compared to that of the lower small intestine. Gorbach et al. (1967) used a 
long polyvinyl tube to sample locations throughout the small intestine and stomach. 
Multiple samples taken from healthy human volunteers showed the upper small intestine 
has low counts (0-10
4
 colonies per milliliter) of both aerobic and anaerobic organisms. 
An important aspect here is the complete absence of coliforms and Bacteroides. As we go 
towards the distal end of the small intestine, the counts were higher (10
3
 – 10
6
 colonies 
per milliliter), and the flora had higher counts of coliforms and Bacteroides.  
 A potential criticism of this type of study is that the presence of the tube itself 
might alter the physiology of the bowel and change the nature of the flora. Another 
important observation was the relationship between the gastric pH and the microfloral 
count. Subjects with higher gastric pH had higher counts of both anaerobes and aerobes 
in the midintestinal aspirates. This supports the concept that gastric acid acts as a barrier 
to the swallowed organisms (Drasar et al. 1969). 
 
Normal microflora of the Large Intestine 
 Several problems are encountered when trying to study the composition of the 
microflora in large intestine. Bacterial counts vary throughout the large bowel, and the 
numbers found in fecal specimens may not accurately represent the counts found in other 
locations of the colon. Bentley et al. (1972) studied patients undergoing elective 
cholecystectomy and compared the microflora of the transverse colon, cecum and 
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terminal ileum with the microflora of the stool specimens. The highest bacterial counts 
were obtained from stool specimens; the mean anaerobic count was 10
9
 colonies per 
gram, and the mean coliform count was 10
7
 colonies per gram. Bacterial counts in the 
terminal ileum were even lower with relatively fewer anaerobes. Although there were 
substantial numerical differences in the counts of bacteria between stool samples and 
samples from various locations in the large intestine, there did not appear marked 
qualitative differences in the flora. Dominant species found in this part of the human gut 
are Clostridia and Bacteroides.  
 
Effect of diet and age on normal intestinal microflora 
 Many factors influence the composition of normal intestinal microflora. Normal 
individuals, when on a chemically defined diet, show a marked reduction in the number 
of organisms in their stool. Fewer studies were performed on the relationship between the 
age and microflora of an individual. The changes that occur in the intestinal microflora 
when a newborn is weaned and introduced to solid food are most likely due to  the effect 
of change in diet rather than change in the age. The fecal flora of children appears to 
closely resemble that of adult fecal flora by the age of 1 year. Ellis-Pegler et al. (1975) 
noted that the concentration of aerobes (particularly streptococci and gram-negative 
facultative bacilli) decreased during the first year of life and anaerobes (particularly 
Bacteroides) became the predominant members of the fecal flora.  
 The effect of advanced age on the intestinal microflora in the adult is another area 
where few data exists. Gorbach et al. (1975) found that elderly subjects harbored fewer 
bifidobacteria but larger number of fungi and coliforms than younger subjects. These 
 5    
 
results were in agreement with studies done by other investigators. However, relatively 
small number of patients have been studied and considerable variation existed among 
individuals of the same age.  
 
1.2 Metabolic activities of the Intestinal Microflora 
 
Low molecular weight carbohydrates 
 Most of the simple sugars and disaccharides that are consumed by the host do not 
reach the colon because they are absorbed as they pass through the small intestine. 
However, small amounts of few simple sugars may reach the colon. Moreover, the 
amount of simple sugars that escape digestion in the small intestine may depend on 
whether the sugars are ingested in a mixture along with complex carbohydrates. For 
example, certain types of polysaccharides can decrease the rate of glucose absorption 
from the small intestine (Holt et al., 1979; Schwarz and Levine, 1980). Thus, it is 
possible that small amounts of few simple sugars or disaccharides in foods reach the 
colon.  
 
Dietary polysaccharides 
 Dietary fiber, which are plant cell wall polysaccharides, comprise a significant 
portion of many human foods. Nutritional studies have indicated that most of the dietary 
fiber is not excreted. As the human intestinal enzymes cannot degrade plant cell wall 
polysaccharides, the degradation of dietary fiber has been attributed to fermentation by 
colonic bacteria. Since at least 50% of dietary fiber is digestible by colonic bacteria (Van 
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Soest, 1978), the carbohydrate in dietary fiber could provide a substantial portion of the 
resources needed to maintain the bacterial mass in the colon.  
 Previous studies have shown that members of Bacteroides are most active 
fermenters of plant polysaccharides. Members of the genus Bacteroides account for about 
20% of all fecal isolates (Moore and Holdeman, 1974; Holdeman et al., 1976). But it is 
incorrect to conclude that most of the catabolism of dietary fiber is done by Bacteroides 
as the studies have been done using pure cultures and the isolated polysaccharides in 
artificial medium, and thus they may not take into account many of the factors that are 
inherent in the actual gut environment.  
 
Polysaccharides produced by the host  
 The host itself produces complex carbohydrates that can be utilized by the colon 
bacteria. In rats and presumably in humans, the intestinal mucosa is completely replaced 
once in every 4-5 days (Lipkin, 1973). In addition to the mucosal cells which are 
constantly given out into the intestinal lumen, the host produces large amounts of saliva, 
gastric juice and mucinous secretions, all of these products contain glycoproteins, and 
there is some evidence that host products are utilized by microflora in vivo. Hoskins and 
Boulding (1976) have shown that human fecal homogenates can degrade blood 
glycoproteins. The organisms responsible for this have not been isolated and identified, 
but Miller and Hoskins (1981) have estimated that these organisms account for 1% of the 
total population of bacteria in the colon.  
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Biotransformation of Bile acids and Cholesterol 
 The intestinal microflora of man and animals can transform bile acids and 
cholesterol into a variety of metabolites (Hayakawa, 1973). Known microbial 
biotransformations include hydrolysis of conjugated bile acids to yield free acids 
(Hylemon et al., 2006). The extent of degradation is limited by the constraints inherent in 
the strictly anaerobic environments of the colon. In man, the microflora can generate at 
least 15-20 different bile acids from the primary bile acids. The biotransformation 
markedly alters the physical characteristics as well as the physiological effects of steroid 
molecules.  
 
 
1.3 Gastrointestinal disorders 
 Metchnikoff (1907) suggested that bacteria inhabiting the human intestine 
affected health and longevity of the host. Most of the diseases that occur in the human 
intestine are of unknown origin, but bacteria have been shown either as causative agents 
or maintenance factors involved in many colonic disorders. A number of species are able 
to upset the normal gut homeostasis and cause an acute inflammatory response. The 
principal organisms involved are enterotoxigenic strains of Escherichia coli, as well as 
species belonging to genera Salmonella, Shigella, Campylobacter, and Yersinia. 
Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS) are thought to 
have an origin connected with the activities of gut flora.  
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1.3.1 Inflammatory Bowel Disease 
 Two major instances of Inflammatory Bowel Disease are Ulcerative Colitis (UC) 
and Crohn’s disease (CD). Both conditions involve an inflammatory reaction and share 
many clinical features, which make individual diagnosis difficult. Marked difference is 
that CD affects primarily the small intestine and all regions of large intestine, whereas 
UC usually affects the distal colon (Whitehead 1989).  
Ulcerative Colitis 
 The inflammatory response of UC is primarily located in the colonic 
mucosa and sub mucosa. The distal colon is always affected with the condition 
expressing itself in acute attacks followed by periods of symptom free remission. 
Bacterial involvement has been suggested in both initiation and maintenance 
stages of UC (Hill 1986). Streptococcus mobilis, Fusobacteria and Shigella have 
been attributed as specific causative agents (Onderdonk 1983, Campieri 2001), 
largely because these organisms are either able to penetrate the gut mucosal 
epithelium or cause similar disease symptoms in animals. More direct and 
convincing evidence exists for a bacterial role in disease maintenance 
(Cummings et al., 2003).  
 Crohn’s Disease 
 According to Chadwick (1991), Eubacterium, Peptostreptococcus, 
Pseudomonas, Bacteroides vulgates and Clostridium difficile are associated with 
the onset of Crohn’s disease. Because this particular disease involves a 
granulomatous reaction, it is more likely that a persistent stimulus is involved. 
Mycobacteria are thoroughly studied in this respect and M. paratuberculosis has 
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been isolated from a number of CD patients (Chidoni et al., 1984; Gitnick et al., 
1985, Graham et al., 1987, Greenstein 2003).  
 
1.3.2 Irritable Bowel Syndrome 
 Irritable bowel syndrome (IBS) is a functional bowel disorder characterized by 
abdominal pain, discomfort, bloating and cramping, relieved by defecation and alteration 
of bowel habits. IBS may also be predominated by diarrhea (IBS-D) or constipation (IBS-
C) or both may alternate (IBS-A). However, the symptoms may vary from person to 
person. Some people have constipation, and report straining and cramping when trying to 
have a bowel movement but cannot eliminate any stool or able to eliminate only a small 
amount. People with diarrhea frequently feel an urgent and uncontrollable need to have a 
bowel movement. Other people with IBS alternate between constipation and diarrhea. 
Some people find that their symptoms subside for a few months and reoccur after a while 
whereas other people report a constant worsening of the symptoms over time.  
 The specific cause of IBS is yet to be discovered. One theory states that people 
who suffer from IBS have a large intestine that is particularly sensitive and reactive to 
certain foods and stress. The immune system may also be involved. Normal motility may 
not be present in the colon of a person suffering from IBS. It can be spasmodic or even 
stop working temporarily. The epithelial lining of the colon regulates the flow of fluids in 
and out of the colon. In IBS, the function of the epithelium appears normal but the 
contents inside the colon move too quickly for the colon to absorb the fluids. The result is 
too much fluid in the stool. In other people, the movement occurs slower than the normal 
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rate which results in extra fluids being absorbed from the contents passing through the 
colon which results in the person developing constipation.   
 Research publications from the later 1990s began identifying the biochemical 
changes present in the tissue and serum samples from IBS patients (Talley et al., 1999, 
Thompson et al 1999, Saito et al 2002). These studies identified cytokines and secretory 
products in tissues taken from IBS patients. A study done on the biopsy samples from 
constipation predominant IBS patients showed elevated levels of serotonin-a 
neurotransmitter. Ninety five percent of the serotonin in the body is located in the GI tract 
and rest is found in brain. Cells that line the inside of the bowel work as transporters of 
serotonin and carry it in and out of the GI tract. People with IBS have diminished 
receptor activity, causing abnormal levels of serotonin in the GI tract. As a result, they 
experience problems with bowel movement, motility and sensation--having more 
sensitive pain receptors in their GI tract.  
 A study on the rectal biopsy tissues from IBS patients showed increased levels of 
cellular structures involved in the production of Interleukin 1-β (K-A Gwee et al., 2003). 
Studies on blood samples from IBS patients showed increased levels of TNF-α, 
Interleukin 1 and Interleukin 6.  
 
 
1.4 Existing methods to diagnose the GI disorders 
 GI disorders are extremely difficult to diagnose because of the characteristic 
symptom overlap among common ailments (like diarrhea). The patient may show no 
symptoms, even if the bowel becomes increasingly damaged for years. Once the 
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symptoms start to show up, they often resemble those of other conditions, making the 
diagnosis difficult.  
 The doctor may go through the ‘medical history’- consisting of the patient’s past 
health, family’s health, any medications he/she is taking, any allergies the patient may 
have and other related issues. Blood tests may be done to determine the signs, if any, of 
the inflammation in the body which are often present with the disease. Analysis of the 
stool sample may be done. Colonoscopy may be done to see inflammation, bleeding or 
ulcers on the wall of the colon.  
 
 
1.5 New and efficient ways to study Microflora 
 Previous studies of the microflora were usually done by culturing the fecal 
samples or the biopsy samples on various kinds of defined media which are specific for 
certain bacterial species. But the drawback in such kind of study is that only limited 
number of microfloral species can be studied. Detailed studies of the microflora using 
such an approach are extremely time consuming and difficult. However, shortcuts lead to 
significant inaccuracies.  
 The advent of new techniques in PCR amplifications, particularly those which use 
16S rDNA as a phylogenetic classifier (Wang Q et al., 2007)  helped to great extent to 
identify most of the unclassified species of the microflora. 16S rDNA is believed to be an 
important phylogenetic classifier because it is believed to be conserved from an 
evolutionary point of view. Many of the members of the microflora are believed to exist 
 12    
 
only on the basis of their 16S rDNA sequence and were never cultured in a laboratory 
due to the lack of proper culture techniques.  
 Microarray technology is another powerful tool that can be used to detect 
thousands of genes/target sequences in a large population. Oligonucleotide probes that 
are complimentary to the 16S rDNA sequences of various species can be synthesized 
directly on the glass slide. The sample population is hybridized to the microarrays to 
interrogate the presence of species of interest. Microarrays provide advantages over the 
PCR amplification studies because of the robust and high throughput analysis.  
 The advantage of oligonucleotide microarrays is the use of photolithographic 
process, by which dense arrays are produced containing numerous copies of a large 
number of different probes in a small area. This allows each array to contain considerable 
probe redundancy and internal standards to evaluate hybridization efficiency (Graves, 
1999). The oligonucleotide array also allows for discrimination based on single base pair 
differences (Nuwaysir et al., 1999). This allows the oligonucleotide arrays to be applied 
in fields of medical diagnosis, pharmacogenetics and sequencing due to their 
hybridization and gene expression analysis capabilities.  
Various kinds of microarrays have been used to study the fecal microbial 
composition including community genome arrays, functional genome arrays, and 
phylogenetic oligonucleotide arrays. Of these, the phylogenetic oligonucleotide arrays are 
best suited to study the microflora because their probe sequences are based upon the 
ribosomal RNA sequences and are ideal for microbial community composition studies.  
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For our study purpose, we have chosen microarrays manufactured by Affymetrix 
Inc. (Santa Clara, CA) (Affymetrix Technical Note 2001). The advantages of the 
Affymetrix based microarrays include: 
• Constructed with a very high precision and accuracy. 
• Have a high probe density, sensitivity and specificity. 
• The use of Perfect Match (PM) and Mismatch (MM) probe pairs offers 
higher selectivity at low target concentrations.  
• Use of multiple probes per sequence or gene allows statistical algorithms 
to provide confidence in microarray results. 
• Probes for many different rDNA genes can be synthesized on a single 
array and thus hundreds of species can be tested in each microfloral 
sample.  
 
1.6 Design of custom-made Microarray  
 The design of the custom-made microarray was carried out by Dr. Oleg Paliy in 
collaboration with Dr. Qiong Wang and Dr. Jim Cole of Ribosomal Database Project at 
Michigan State University. The probes of the microarray were based on the 16S rDNA 
sequences of various bacterial species that are believed to inhabit the human gut. A list of 
16S rDNA sequences of intestinal microflora was compiled by performing a search of 
Entrez Nucleotide Database by using the following search string: 
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“(SSU OR 16S OR small subunit) AND (rRNA OR rDNA OR ribosomal RNA 
OR ribosomal DNA) AND (bacteri* OR prokaryot* OR eubacteri*) AND (human 
OR sapiens OR humam) AND (GI OR colon* OR mucous OR intestin* OR fecal 
OR feces OR faec* OR stool) NOT (archae* OR oral OR esophag*) AND 
1200:1700[SLEN]” 
 The length of sequences retrieved was limited to 1700 base pairs. The search 
returned a total of 15735 microbial sequences which are reported to inhabit the human 
intestine. Manual examination of all the sequences revealed that the compiled list was 
highly redundant and hence the task of narrowing down the list into smaller groups was 
done. The initial dataset of 15735 sequences was grouped into various “Phylo-species”- 
which share a 98% sequences similarity among them. This grouping was done so that any 
newly discovered sequence(s) would fall into any one of the phylo-species. 
The representative sequences of all the phylo-species were constructed and were 
truncated in such a way that the 16S rDNA sequence would fall between nucleotide 
positions 28 and 1491 (E.coli 16S rDNA positions) because this region can be amplified 
using universal 16S rDNA PCR primers. The truncated file was saved and supplied to 
Affymetrix design team as in input for their algorithm. The probe length was restricted to 
25 nucleotides. The minimum number of probes per probeset was 5 and the maximum 
was 11. As controls, standard human, rat and mouse were included on the array. The 
human controls serve to estimate the amount of contaminating human DNA and the 
mouse and rat controls serve as negative controls.  
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Table 1.6.1 Distribution of bacterial 16S rDNA sequences into various phylo-species 
 
 
Class No. of phylo-species 
Cyanobacteria 1 
Alphaproteobacteria 9 
Betaproteobacteria 17 
Gammaproteobacteria 11 
Deltaproteobacteria 4 
Epsilonproteobacteria 6 
Clostridia 527 
Mollicutes 12 
Bacilli 24 
Actinobacteria 29 
Spirochaetes 4 
Bacteroides 126 
Fusobacteria 3 
Verrucomicrobiae 1 
Lentisphaerae 1 
Total 775 
  
In table 1.6.1, the number of phylo-species represents the number of bacterial 
species 16S rDNA sequences that belong to a particular class and have been known to 
reside in the human gut. Clostridia are the dominant members of the human microflora 
followed by Bacteroides.  
 
1.7 Thesis overview  
 The work in this manuscript describes the validation of the custom made 
microarray. The validation experiments were done using 16 different pure bacterial 
cultures that were obtained from ATCC as frozen stocks. Nucleic acids were isolated 
from each bacterial species and PCR amplification of the 16S rDNA was carried out. The 
use of total genomic DNA, PCR-amplified 16S rDNA and total RNA as starting material 
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for hybridization was validated. The detection limit of the microarray when total gDNA 
and amplified 16S rDNA was used was determined. Fold change experiments were done 
to establish a relationship between the expected and observed signal ratios. Finally, as 
confirmatory tests, 4 fecal DNA samples from healthy volunteers-two from children and 
two from adults-were analyzed by the microarray to examine the quantitative differences 
between adults and child microflora composition.  
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2. MATERIALS AND METHODS 
 
2.1 Choice of bacterial strains 
 Before the microarray can be put to actual experimental usage, its ability to 
correctly identify different bacterial species has to be validated. For this purpose, a total 
of 16 different bacterial species have been chosen so that they- 
1. Are available as frozen stocks from ATCC (American Type Culture Collection) 
2. Are culturable  
3. Represent bacteria with different GC content 
4. Represent bacteria from various classes. 
Table 2.1.1 List of bacterial species used for validation experiments 
 
ATCC 
Number 
Bacterial species Group GC 
content 
Gram 
+ve/-ve 
27539 Bifidobacterium catenulatum Actinobacteria ~60 positive 
15707 Bifidobacterium longum Actinobacteria 60 positive 
25559 Eggerthella lenta Actinobacteria 30-40 positive 
27274 Enterococcus faecalis Bacilli 37 positive 
4356 Lactobacillus acidophilus Bacilli 35 positive 
8483 Bacteroides ovatus Bacteroidetes ~43 negative 
8492 Bacteroides uniformis Bacteroidetes ~43 negative 
9689 Clostridium difficile Clostridia 29 positive 
638 Clostridium paraputrificum Clostridia ~32 positive 
9714 Clostridium sordellii Clostridia ~33 positive 
19403 Clostridium sphenoides Clostridia ~34 positive 
8486 Eubacterium limosum Clostridia 30-40 positive 
27210 Ruminococcus albus Clostridia ~42 negative 
51649 Holdemania filiformis Mollicutes 38 positive 
25586 Fusobacterium nucleatum Fusobacteria 27 negative 
25922 Escherichia coli Gammaproteobacteria 51 negative 
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The strains were obtained as frozen cultures from ATCC and stored at -80
0
C until 
final use. The cells were grown either in 15ml centrifuge flasks or T-25 tissue culture 
flasks. Aerobic cultures were grown in water shaker at 37
0
C until desired OD600 is 
reached. Anaerobic were grown in sealed GasPak bag with a gas generator packet (BD 
GasPak EZ) until sufficient density of cells is reached. Then the cells were spun down, 
washed in ice-cold PBS (4
0
C), centrifuged, and then frozen at -80
0
C.  
 
 
2.2 Isolation of nucleic acids 
 The nucleic acids were obtained from all the cell cultures using ZR 
Fungal/Bacterial DNA Isolation Kit (Zymo Research) as per the following protocol: 
a. Weigh about 100 mg of pellet and resuspend in 200ul of PBS. 
b. Add 750 µl of lysis buffer supplied with the kit. 
c. Transfer the contents into a ZR BashingBead™ Lysis Tube and vortex at 
maximum speed for 5 min. 
d. Centrifuge the ZR BashingBead™ Lysis Tube in a micro centrifuge at  
10,000 x g for 1min. 
e. Transfer 400 µl of supernatant onto Zymo-Spin™ IV Spin Filter in a 
collection tube and centrifuge at 7,000 rpm for 1min. 
f. Add 1,200 µl of Fungal/Bacterial DNA binding buffer to activate the filtrate 
in the collection tube. 
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g. Transfer 800 µl of the filtrate in above step to Zymo-Spin™ IIC Column in a 
collection tube and centrifuge at 10,000 x g for 1 min. Discard the flow 
through and repeat the step. 
h. Add 200 µl of DNA prewash buffer to the Zymo-SpinTM IIC column in a new 
collection tube and centrifuge at 10,000 x g for 1 min. 
i. Add 500 µl of Fungal/Bacterial DNA Wash Buffer to the column and 
centrifuge at 10,000 x g for 1min. 
j. Transfer the Zymo-SpinTM IIC column to a clean 1.5 ml centrifuge tube and 
elute the DNA in 100 µl of nuclease-free H2O by centrifuging at 10,000 x g 
for 30 seconds. 
The nucleic acids were isolated following the above protocol. The DNA was 
resuspended in nuclease-free water and the absorbance was measured using a 
spectrophotometer to estimate the amount of DNA obtained from the pellets. A 1% 
agarose gel was run to check the purity and integrity of the nucleic acids isolated from all 
the bacterial species. 
 The above two steps, i.e., culturing of the species and isolation of nucleic acids 
from the cell pellets, were performed by Dr. Frank Abernathy at Dayton Children’s 
Hospital.  
 
 
2.3 PCR amplification of 16S rDNA 
The amplification of 16S rDNA was carried out from all species by using two 
primers Amp_27F [AGAGTTTATC(C/A)TGGCTCAG] and Bact_1492R 
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[TACGG(C/T)TACCTTGTTACGACTT] , which are considered universal for most 
bacterial species. The reaction was carried out in 50 µl volume using Takara PrimeStar 
HotStart DNA Polymerase. Seventy five nanograms of pure bacterial DNA was used as 
starting material and the reaction was carried for 25 cycles. 
Table 2.3.1 Reaction mixture for PCR amplification of 16S rDNA 
 
Component Amount 
DNA template 75ng 
Primer-1 (100 µM) 1 µl 
Primer-2 (100 µM) 1 µl 
2.5 mM dNTP Mix 4 µl 
DNA Polymerase 1 µl 
Nuclease free H2O up to 50 µl 
Total reaction volume 50 µl 
 
The amplified DNA was purified using Qiagen QIAquick PCR purification kit. 
The purified DNA was resuspended in nuclease-free water and the absorbance was 
measured using a spectrophotometer to estimate the nucleic acid yield. A 1% agarose gel 
was run to check the presence of a single band at 1500 basepairs position and confirm the 
amplification was correct and also to check the integrity of the sample. 
 
 
2.4 Fragmentation of the amplified DNA 
 For hybridization onto the microarrays, fragmentation of the nucleic acids has to 
be performed to reduce the size of the DNA fragments to 100-300 basepairs (bp). A 
series of fragmentation experiments were performed to check for the concentration of 
DNase I enzyme that would give us the desired range of fragment length. It has been 
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determined that 0.075 U enzyme/µg of DNA produced the optimum range of fragments. 
The fragmentation was performed by incubating the DNA with reaction buffer and 
DNase I enzyme at 37
o
C for 10 min, followed by inactivation of the enzyme at 98
o
C for 
another 10 min. The fragmentation was verified for proper fragment size by running the 
fragmented sample on a 10% polyacrylamide gel.   
2.5 Terminal labeling of the fragmented DNA 
 The fragmented DNA product was end-labeled with biotin in a terminal 
transferase reaction following standard Affymetrix protocol.  
Table 2.5.1 Labeling reaction mixture 
 
Component Amount 
fragmented DNA as required 
10X Reaction buffer 10 µl 
Genechip Labeling reagent 2 µl 
Terminal Transferase 2 µl 
Nuclease-free H2O up to 50 µl 
Total reaction volume 50 µl 
  
 The reaction mixture was prepared as described in Table 2.5.1 and was incubated 
at 370C for 60 min. The labeling was stopped by adding 2 µl of 0.5 M EDTA. The labeled 
product was ready to be hybridized onto the microarrays or alternately would be stored at 
-200C for future use.  
 
2.6 Hybridization onto the microarrays 
 The hybridization solution was prepared as described below: 
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Table 2.6.1 Hybridization mix 
Component Amount 
2X Hybridization buffer 65 µl 
3 nM Control oligos 2.2  µl 
10 mg/ml Herring Sperm DNA 1.3  µl 
50 mg/ml BSA 1.3  µl 
100 % DMSO 10.2  µl 
Fragmented and labeled DNA up to 50  µl 
Total volume 130  µl 
  
 The probe array was equilibrated to room temperature immediately before use. 
The indicated amount of hybridization solution mixture was added to the probe array. 
The hybridization oven was preheated to 45
0
C and the array was hybridized at the set 
temperature for 16 hours. After 16 hrs of hybridization, the hybridization cocktail from 
the probe array was removed and was replaced completely with appropriate volume of 
Non-Stringent Wash Buffer. The staining and washing solutions were prepared on the 
day of washing. Using the appropriate protocol for washing and staining of the probe 
array in the fluidics station, it was properly processed and scanned using a GeneChip 
Scanner 3000.  
 
2.7 Isolation of DNA from fecal samples 
 DNA from fecal samples was isolated by Dr. Frank Abernathy at Dayton 
Children’s Hospital using ZR Fecal DNA Kit (Zymo Research) following the protocol 
supplied by the manufacturer: 
1. Add up to 150 mg of fecal sample to a ZR BashingBead™ Lysis Tube. Add 750 µl 
Lysis Buffer to the tube. 
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2. Secure in a bead beater fitted with a 2 ml tube holder assembly (e.g., Disruptor 
Genie™) and process at maximum speed for 5 minutes. 
3. Centrifuge the ZR BashingBead™ Lysis Tube in a microcentrifuge at ≥10,000 x g for 
1 minute. 
4. Transfer up to 400 µl supernatant to a Zymo-Spin™ IV Spin Filter (orange top) in a 
Collection Tube and centrifuge at 7,000 rpm (~7,000 x g) for 1 minute. 
5. Add 1,200 µl of Fecal DNA Binding Buffer to the filtrate in the Collection Tube from 
Step 4. 
6. Transfer 800 µl of the mixture from Step 5 to a Zymo-Spin™ IIC Column in a 
Collection Tube and centrifuge at 10,000 x g for 1 minute. 
7. Discard the flow through from the Collection Tube and repeat Step 6. 
8. Add 200 µl DNA Pre-Wash Buffer to the Zymo-Spin™ IIC Column in a new 
Collection Tube and centrifuge at 10,000 x g for 1 minute. 
9. Add 500 µl Fecal DNA Wash Buffer to the Zymo-Spin™ IIC Column and centrifuge 
at 10,000 x g for 1 minute. 
10. Transfer the Zymo-Spin™ IIC Column to a clean 1.5 ml microcentrifuge tube and 
add 100 µl DNA Elution Buffer directly to the column matrix. Centrifuge at 10,000 x g 
for 30 seconds to elute the DNA. 
11. Transfer the eluted DNA from Step 10 to a prepared Zymo-Spin™ IV-HRC Spin 
Filter (green top) (see above) in a clean 1.5 ml microcentrifuge tube and centrifuge at 
exactly 8,000 x g for 1 minute. The filtered DNA is now suitable for PCR and other 
downstream applications. 
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3. RESULTS 
3.1 Isolation of total genomic DNA from the bacterial species 
 Genomic DNA was isolated from all the 16 bacterial species using ZR 
Fungal/Bacterial DNA Isolation Kit (Zymo Research). A 1% agarose gel was run to 
check the purity and integrity of the nucleic acids.  
 
 
Figure 3.1.1:  1% Agarose gel of all bacterial genomic DNAs.  
Each lane in the gel was loaded with 2 µl of genomic DNA sample. 1 µl of 2-log 
DNA ladder from NEB was used as size markers.  The lanes on the gel correspond to: 
A: Holdemania filiformis, B: Ruminococcus albus, C: Eggerthella lenta, D: Bacteroides 
uniformis, E: Enterococcus faecalis, F: Lactobacillus acidophilus, G: Clostridium 
paraputrificum, H: Clostridium difficile, I: Clostridium sordellii, J: Clostridium 
sphenoides, K: Bacteroides ovatus, L: Eubacterium limosum, M: Bifidobacterium 
 25    
 
longum, N: Bifidobacterium catenulatum, O: Fusobacterium nucleatum, P: Escherichia 
coli.  
Figure 3.1.1 shows that all the species gave good amounts of nucleic acids except 
Ruminococcus albus, which had a low yield. Hence, it was not used extensively in our 
experiments.  
 
3.2 Identification of individual species by the microarray 
 Initially, we wanted to test whether the microarray can correctly identify 
individual species when pure gDNA from each species was hybridized to individual 
microarrays. For these experiments, 250 ng of gDNA from individual species were taken 
and were fragmented with 0.075 U/µg of DNase I. The fragmentation product was 
visualized by running on a 10% polyacrylamide gel to make sure that we obtained desired 
fragment length. The fragmented product was then end labeled with biotin in a terminal 
transferase reaction and the biotin-labeled product was hybridized onto microarrays. Only 
one bacterial species was used per microarray.  
 We wanted to determine the optimum values of concentration of the DNase I 
enzyme and the time of fragmentation required. Experiments were done with various 
concentrations of DNase I enzyme and various incubation times and the fragmented 
products were run on a 10% polyacrylamide gel to visualize the fragmented product. All 
of the fragmented product was loaded onto the gel. Five microlitres of Tri-dye ladder 
(100bp-1500bp) from NEB were loaded onto the gel and used as DNA fragment size 
markers. We wanted most of the fragments to fall in the range of 100-300bp. 
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Figure 3.2.1 10% polyacrylamide gel of the experiments to determine optimum 
concentration of the DNase I enzyme and time of fragmentation. ‘Un’ represents the 
unfragmented total genomic DNA sample. L corresponds to the Tri-dye ladder from 
NEB. The samples to the right of the ladder represent the various concentrations of 
the DNase I enzyme in U/µg of sample and the numbers in parenthesis below the 
concentrations denote the time of fragmentation. 
 From the figure 3.2.1, 0.075 U/µg of DNA gave the ideal fragment size. Hence 
this concentration of the DNase I enzyme is used as standard concentration and is used in 
all further experiments which involve the fragmentation of the total genomic DNA 
sample for hybridization onto the microarrays. For the experiments where fragmentation 
of the PCR-amplified 16S rDNA is used, DNase concentration of 0.04 U/µg of DNA was 
used because the 16S rDNA is 1500 bp long and the use of higher concentrations may 
lead to overfragmentation of the nucleic acid sample.
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Table 3.2.1 Identification of individual species by microarray when total gDNA was used 
 
 
          
 
          Amt: Amount of gDNA hybridized to chip 
          Det: Detection P- Present/A-Absent/M-Marginal 
 
   Continued on next page… 
 
 
 Expt 1 Expt 2 Expt 3 Expt 4 Expt 5 Expt 6 Expt 7 Expt 8 
Bacterial species Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det 
Bifidobacterium longum 250ng P - A - A - A - A - A - A - A 
Bifidobacterium catenulatum - A 250ng P - A - A - A - A - A - A 
Eggerthella lenta - A - A 250ng A - A - A - A - A - A 
Bacteroides uniformis - A - A - A 250ng P - A - A - A - A 
Bacteroides ovatus - A - A - A - A 250ng P - A - A - A 
Enterococcus faecalis - A - A - A - A - A 250ng P - A - A 
Lactobacillus acidophilus - A - A - A - A - A - A 250ng P - A 
Ruminococcus albus - A - A - A - A - A - A - A 250ng P 
Clostridium paraputrificum - A - A - A - A - A - A - A - A 
Clostridium difficile - A - A - A - A - A - A - A - A 
Clostridium sordellii - A - A - A - A - A - A - A - A 
Clostridium sphenoides - A - A - A - A - A - A - A - A 
Eubacterium limosum - A - A - A - A - A - A - A - A 
Holdemania filiformis - A - A - A - A - A - A - A - A 
Fusobacterium nucleatum - A - A - A - A - A - A - A - A 
Escherichia coli - A - A - A - A - A - A - A - A 
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Table 3.2.1 Identification of individual species by microarray when total gDNA was used (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amt: Amount of gDNA hybridized to chip 
          Det: Detection P- Present/A-Absent/M-Marginal 
 
 Expt 9 Expt 10 Expt 11 Expt 12 Expt 13 Expt 14 Expt 15 Expt 16 
Bacterial species Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det 
Bifidobacterium longum - A - A - A - A - A - A - A - A 
Bifidobacterium catenulatum - A - A - A - A - A - A - A - A 
Eggerthella lenta - A - A - A - A - A - A - A - A 
Bacteroides uniformis - A - A - A - A - A - A - A - A 
Bacteroides ovatus - A - A - A - A - A - A - A - A 
Enterococcus faecalis - A - A - A - A - A - A - A - A 
Lactobacillus acidophilus - A - A - A - A - A - A - A - A 
Ruminococcus albus - A - A - A - A - A - A - A - A 
Clostridium paraputrificum 250ng P - A - A - A - A - A - A - A 
Clostridium difficile - A 250ng P - A - A - A - A - A - A 
Clostridium sordellii - A - A 250ng P - A - A - A - A - A 
Clostridium sphenoides - A - A - A 250ng P - A - A - A - A 
Eubacterium limosum - A - A - A - A 250ng P - A - A - A 
Holdemania filiformis - A - A - A - A - A 250ng P - A - A 
Fusobacterium nucleatum - A - A - A - A - A - A 250ng P - A 
Escherichia coli - A - A - A - A - A - A - A 250ng P 
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 From Tables 3.2.1, the microarray correctly identified 15 of the total 16 bacterial 
species used.  Eggerthella lenta was called absent. We then wanted to see whether the 
microarray can detect individual species when all the nucleic acids were pooled together. 
100ng of gDNA from each individual species (except Ruminococcus albus) were pooled 
into a mixture. The mixture was fragmented with 0.075U/µg of DNase I. The fragmented 
product was end labeled with biotin in a terminal transferase reaction and hybridized onto 
the microarray. 
 
Figure 3.2.1 shows the scanned image of the microarray when all the samples 
were pooled together. Table 3.2.4 shows the detection of the individual species when all 
the gDNAs were pooled together. The microarray correctly identified 15 out of a total of 
16 individual species when all the pure gDNAs were pooled together into a mixture. 
Eggerthella lenta was called absent. 
Figure 3.2.2: Scanned image of the microarray experiment where all the gDNAs 
were pooled together and hybridized onto the microarray 
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Table 3.2.2: Detection of individual species when all the gDNAs were pooled 
together 
 
Bacterial species Amt Det 
Bifidobacterium longum 100ng P 
Bifidobacterium catenulatum 100ng P 
Eggerthella lenta 100ng A 
Bacteroides uniformis 100ng P 
Bacteroides ovatus 100ng P 
Enterococcus faecalis 100ng P 
Lactobacillus acidophilus 100ng P 
Ruminococcus albus - - 
Clostridium paraputrificum 100ng P 
Clostridium difficile 100ng P 
Clostridium sordellii 100ng P 
Clostridium sphenoides 100ng P 
Eubacterium limosum 100ng P 
Holdemania filiformis 100ng P 
Fusobacterium nucleatum 100ng P 
Escherichia coli 100ng P 
 
Amt: Amount of gDNA hybridized to chip 
     Det: Detection P- Present/A-Absent/M-Marginal 
 
 
3.3 PCR amplification of 16S rDNA  
 The near full length of 16S rDNA was amplified from all the bacterial species 
using two universal (phylogenetically conserved) primers- Amp_27F and Bact_1492R, 
which bind to conserved regions of the 16S rDNA gene. 75ng of gDNA was used as 
starting material in each case and the amplification was carried out for 25 cycles. The 
reaction products were purified using Qiagen PCR Purification Kit and the purified 
product was run on a 1% agarose gel to check the size of the amplified band and also the 
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integrity of the samples. Two microlitres of amplified 16S rDNA sample was loaded onto 
the gel.  
 
 
Figure 3.3.1: 1% Agarose gel of PCR amplification of 16S rDNA 
A: Holdemania filiformis, C: Eggerthella lenta, D: Bacteroides uniformis, E: 
Enterococcus faecalis, F: Lactobacillus acidophilus, G: Clostridium paraputrificum, H: 
Clostridium difficile, I: Clostridium sordellii, J: Clostridium sphenoides, K: Bacteroides 
ovatus, L: Eubacterium limosum, M: Bifidobacterium longum, N: Bifidobacterium 
catenulatum, O: Fusobacterium nucleatum, P: Escherichia coli.  
In the above figure, the control represents the unamplified total genomic DNA. 1 
µl of 2-log DNA ladder (NEB) was used as DNA size markers and a nucleic acid band 
that corresponds to size of 1500 basepairs can be seen in all the lanes. This is the 16S 
rDNA from each species and it shows that the universal primers were effective in 
amplifying the 16S rDNA from all the bacterial species tested.  
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The amplified DNA is smaller in length (1.5Kb) than average fragment size of 
isolated genomic DNA and as a result was fragmented with 0.04 U/µg of DNase I 
because prior experiments showed that this concentration of the enzyme gave the 
optimum fragment size for hybridization onto the microarrays. A part of the fragmented 
product was run on a 10% polyacrylamide gel to check whether the fragmentation 
worked or not. 
 
Figure 3.3.2: 10% Polyacrylamide gel for Fragmentation-I 
1/10
th
 of the fragmentation mixture was run on a 10% polyacrylamide gel to check the 
size of the fragments obtained. L: Tridye DNA ladder 100bp-1500bp (NEB) – used as 
DNA size markers 
A: Holdemania filiformis, B: Ruminococcus albus, C: Eggerthella lenta, D: Bacteroides 
uniformis, E: Enterococcus faecalis, F: Lactobacillus acidophilus, G: Clostridium 
paraputrificum, H: Clostridium difficile 
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Figure 3.3.3: 10% Polyacrylamide gel for Fragmentation-II 
L: Tri-dye DNA ladder 100bp-1500bp (NEB) – used as DNA size markers.  
I: Clostridium sordellii, J: Clostridium sphenoides, K: Bacteroides ovatus, L: 
Eubacterium limosum, M: Bifidobacterium longum, N: Bifidobacterium catenulatum, O: 
Fusobacterium nucleatum, P: Escherichia coli 
The fragmented products were end labeled with biotin in a terminal transferase reaction 
and hybridized onto microarrays. Only one sample was hybridized per array.
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Table 3.3.1 Identification of individual species by microarray when 16S rDNA was used 
 
    
          Amt: Amount of gDNA hybridized to chip 
          Det: Detection P- Present/A-Absent/M-Marginal 
 
Continued on next page 
 
 
 
 Expt 1 Expt 2 Expt 3 Expt 4 Expt 5 Expt 6 Expt 7 Expt 8 
Bacterial species Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det 
Bifidobacterium longum 250ng P - A - A - A - A - A - A - A 
Bifidobacterium catenulatum - A 250ng P - A - A - A - A - A - A 
Eggerthella lenta - A - A 250ng A - A - A - A - A - A 
Bacteroides uniformis - P - A - A 250ng P - A - P - A - A 
Bacteroides ovatus - A - A - M - A 250ng P - A - A - A 
Enterococcus faecalis - A - M - A - A - A 250ng P - A - A 
Lactobacillus acidophilus - A - A - A - A - A - A 250ng P - A 
Ruminococcus albus - A - A - A - A - A - A - A 250ng P 
Clostridium paraputrificum - P - A - A - A - A - A - A - A 
Clostridium difficile - P - A - A - A - A - A - A - A 
Clostridium sordellii - M - A - A - A - A - A - A - A 
Clostridium sphenoides - A - A - A - A - A - A - A - A 
Eubacterium limosum - A - A - A - A - A - A - A - A 
Holdemania filiformis - A - A - A - A - A - A - A - A 
Fusobacterium nucleatum - A - A - A - A - A - A - A - A 
Escherichia coli - A - A - A - A - A - A - A - A 
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Table 3.3.1 Identification of individual species by microarray when 16S rDNA was used (continued) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amt: Amount of gDNA hybridized to chip 
          Det: Detection P- Present/A-Absent/M-Marginal 
 
 
Expt 9 Expt 10 Expt 11 Expt 12 Expt 13 Expt 14 Expt 15 Expt 16 
Bacterial species Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det Amt Det 
Bifidobacterium longum - A - A - A - A - A - A - A - A 
Bifidobacterium catenulatum - A - A - A - A - A - A - A - M 
Eggerthella lenta - A - A - A - A - A - A - A - A 
Bacteroides uniformis - P - A - A - A - A - P - A - A 
Bacteroides ovatus - A - A - A - A - M - A - A - A 
Enterococcus faecalis - A - A - A - A - A - A - A - A 
Lactobacillus acidophilus - A - A - A - A - A - A - A - A 
Ruminococcus albus - A - A - A - A - M - A - A - A 
Clostridium paraputrificum 250ng P - A - P - P - A - A - A - A 
Clostridium difficile - A 250ng P - M - P - A - A - A - A 
Clostridium sordellii - A - P 250ng P - A - A - A - A - A 
Clostridium sphenoides - A - P - A 250ng P - A - A - A - A 
Eubacterium limosum - A - A - A - A 250ng P - A - A - A 
Holdemania filiformis - A - A - A - A - A 250ng P - A - A 
Fusobacterium nucleatum - A - A - A - A - A - A 250ng P - A 
Escherichia coli - A - A - A - A - A - A - A 250ng P 
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 From the above results, it can be seen that 15 of a total of 16 species were 
correctly identified when amplified 16S rDNA was used, except in case of Eggerthella 
lenta which was again called absent. This will be discussed in the next section. It can be 
seen that there were a few cases where the target sequence cross-hybridized to probes of 
other species. There were cross hybridizations of the targets to probes of other species, 
for example, in Expt 1, Bacteroides and Clostridia were also called present. These cross 
hybridizations were shown to be reduced by the use of replicates. For example, the 
experiment in which amplified 16S rDNA from Clostridium sphenoides was hybridized 
onto the microarray, the DNA from that species cross hybridized to 21 other probes. The 
same experiment was repeated again exactly as it was done before. 
Table 3.3.2 Experiment to test reduction of cross hybridization using replicates 
 
 
 
 
original experiment replicate
S051_Clostridium_x_at S051_Clostridium_x_at
S052_Clostridium_at S162_Acetivibrio_at
S052_Clostridium_x_at S270_Ruminococcus_at
S054_Clostridium_at S336_Ruminococcus_x_at
S087_Anaerotruncus_x_at S807_Prevotella_at
S226_Anaerostipes_at S827_Prevotella_at
S233_Coprococcus_x_at
S257_Roseburia_x_at
S270_Ruminococcus_at
S270_Ruminococcus_x_at
S348_Ruminococcus_at
S353_Roseburia_at
S487_Clostridium_at
S487_Clostridium_x_at
S494_Roseburia_at
S573_Papillibacter_at
S579_Roseburia_at
S579_Roseburia_x_at
S581_Roseburia_x_at
S599_Lachnobacterium_at
S620_Holdemania_at
S851_Victivallis_at
Clostridium sphenoides cross hybridization to other probes
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 Table 3.3.2 shows the results of the repeat of the experiment where 16S rDNA 
from Clostridium sphenoides was used as target. In the second experiment, the target 
cross hybridized to only 5 other probes.  
We then wanted to see whether the microarray can identify individual species 
correctly when all the samples of 16S rDNA were pooled together. 100ng of 16S rDNA 
from each species was taken and pooled together. The mixture was fragmented using 
0.04 U/µg of DNase I enzyme. The fragmentation product was end labeled with biotin 
and then hybridized onto the microarrays.  
Table 3.3.3 shows the results of experiments. The microarray correctly identified 
15 out of a total of 16 species correctly. Eggerthella lenta was called as absent.  Figure 
3.3.4 shows the scanned image of the microarray when all the PCR-amplified 16S rDNAs 
were pooled together, which shows increased detection sensitivity of the microarray in 
terms of the florescence of the probes when compared to the use of total genomic DNA 
(Figure 3.2.4).  
Later, a negative control experiment was carried out where no DNA sample was 
added to hybridization mix. This experiment was important to ensure that the herring 
sperm DNA and the control oligonucleotides that are added to the hybridization mix do 
not interfere with the actual target DNA sample during the hybridization process.  
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Table 3.3.3: Identification of individual species by the microarray when 16S rDNA 
from individual species were pooled together 
Bacterial species Amt Det 
Bifidobacterium longum 100ng P 
Bifidobacterium catenulatum 100ng P 
Eggerthella lenta 100ng A 
Bacteroides uniformis 100ng P 
Bacteroides ovatus 100ng P 
Enterococcus faecalis 100ng P 
Lactobacillus acidophilus 100ng P 
Ruminococcus albus - - 
Clostridium paraputrificum 100ng P 
Clostridium difficile 100ng P 
Clostridium sordellii 100ng P 
Clostridium sphenoides 100ng P 
Eubacterium limosum 100ng P 
Holdemania filiformis 100ng P 
Fusobacterium nucleatum 100ng P 
Escherichia coli 100ng P 
     Amt: Amount of gDNA hybridized to chip 
     Det: Detection P- Present/A-Absent/M-Marginal 
 
Figure 3.3.4: Scanned image of the microarray when all 16S rDNA samples are 
pooled together 
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Figure 3.3.5: Negative control experiment where in no DNA sample is added to the 
hybridization mixture. 
  
Figure 3.3.5 shows the image of the microarray scanned by the GeneChip 3000 
Scanner. The negative control experiment produced significantly lower signal for a 
particular probe/species to be called present, indicating that neither the herring sperm 
DNA nor the control oligonucleotides that are added to the hybridization mixture 
interfere with the actual sample during the hybridization process.  
 
3.4 Detection limit of the Microarray 
3.4.1 In the absence of human gDNA 
 We wanted to find the lowest amount of the nucleic acid sample that can be 
detected when hybridized to the microarray. For this, we have chosen only four different 
bacterial species, Bifidobacterium longum, Bacteroides uniformis, Lactobacillus 
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acidophilus and Clostridium sphenoides. We have chosen only these four species because 
these samples had the highest nucleic acid yield.  
 Total genomic DNA from the above four species was pooled together and 
fragmented using 0.075 U/µg of DNase I. A part of the fragmented product was run on a 
10% polyacrylamide gel to check that the fragment size was within the desired range. 
Then the fragmented product was end labeled with biotin in a terminal transferase 
reaction and then hybridized onto the microarray. 
Table 3.4.1.1 Detection limit of the microarray when total gDNA was used in the 
absence of human gDNA 
Bacterial species Amt Det 
Bifidobacterium  longum 10ng P 
Bifidobacterium  catenulatum - A 
Eggerthella  lenta - A 
Bacteroides  uniformis 50ng P 
Bacteroides  ovatus - A 
Enterococcus  faecalis - A 
Lactobacillus  acidophilus 1ng  A 
Ruminococcus  albus - A 
Clostridium  paraputrificum - A 
Clostridium  difficile - A 
Clostridium  sordellii - A 
Clostridium  sphenoides 200ng P 
Eubacterium  limosum - A 
Holdemania  filiformis - A 
Fusobacterium  nucleatum - A 
Escherichia  coli - A 
 
Amt: Amount of gDNA hybridized to chip 
     Det: Detection P- Present/A-Absent/M-Marginal 
 
 Above results shows that 10ng of gDNA could be detected by the microarray in 
the absence of human gDNA.  
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3.4.2 In the presence of human gDNA 
 The experiment was done in the same way as above, but this time in presence of 
human gDNA. The human gDNA isolated from HeLa cells was kindly donated by Dr. 
Leffak. All the DNAs were pooled together along with the human DNA. The mixture was 
fragmented using 0.075 U/µg of DNase I enzyme. The fragmented product was end-
labeled with biotin in a terminal transferase reaction and hybridized onto the microarray. 
Table 3.4.2.1 Detection limit of the microarray in presence of human gDNA when 
total gDNA was used 
Bacterial species Amt Det 
Bifidobacterium  longum 10ng P 
Bifidobacterium  catenulatum - A 
Eggerthella  lenta - A 
Bacteroides  uniformis 50ng P 
Bacteroides  ovatus - A 
Enterococcus  faecalis - A 
Lactobacillus  acidophilus 1ng  A 
Ruminococcus  albus - A 
Clostridium  paraputrificum - A 
Clostridium  difficile - A 
Clostridium  sordellii - A 
Clostridium  sphenoides 200ng P 
Eubacterium  limosum - A 
Holdemania  filiformis - A 
Fusobacterium  nucleatum - A 
Escherichia  coli - A 
Human gDNA 3.74µg P 
 
Amt: Amount of gDNA hybridized to chip 
     Det: Detection P- Present/A-Absent/M-Marginal 
 
 From the Table 3.4.2.1, it can be seen that the lowest amount that could be 
detected by the microarray was 10ng total genomic DNA when used along with human 
gDNA. The signal obtained is higher in the experiment where no human gDNA was used 
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as compared to the experiment where human gDNA was used. This is thought to be due 
to the fact that the amount of human gDNA added is several fold higher in concentration 
which is near saturation and this somehow limits the accessibility of the actual target 
sequences towards their respective probes. In order to see if we could detect amounts 
greater than 1ng but smaller than 10ng when the bacterial total gDNA was used in 
presence of human gDNA, we did a new experiment where 4ng each of bacterial gDNAs 
were used in addition to 4.0µg of human gDNA. The DNA mixture was fragmented using 
0.075 U/µg of DNase I. 
Table 3.4.2.2 Detection limit of the microarray in presence of human gDNA 
 
Bacterial species Amt Det 
Bifidobacterium  longum 4ng P 
Bifidobacterium  catenulatum - A 
Eggerthella  lenta - A 
Bacteroides  uniformis 4ng A 
Bacteroides  ovatus - A 
Enterococcus  faecalis - A 
Lactobacillus  acidophilus 4ng  P 
Ruminococcus  albus - A 
Clostridium  paraputrificum - A 
Clostridium  difficile - A 
Clostridium  sordellii - A 
Clostridium  sphenoides 4ng P 
Eubacterium  limosum - A 
Holdemania  filiformis - A 
Fusobacterium  nucleatum - A 
Escherichia  coli - A 
Human gDNA 4.0µg P 
 
Amt: Amount of gDNA hybridized to chip 
     Det: Detection P- Present/A-Absent/M-Marginal 
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 From the Table 3.4.2.2, it can be seen that in 3 of 4 cases, the microarray could 
detect 4ng of sample. Hence, we established the detection limit of the microarray to be at 
least 4ng of total unamplified genomic DNA.  
3.4.3 Detection limit of the microarray when PCR-amplified 16S rDNA was used 
 Total gDNA from the previously used four bacterial species was taken in similar 
amounts and subjected to 10 cycles of PCR amplification. The amplified product was 
fragmented using 0.04 U/µg of DNase I and hybridized onto the microarray. 
Table 3.4.3.1 Detection limit when PCR-amplified 16S rDNA was used 
 
 No human 
gDNA 
Presence of 
human 
gDNA 
Bacterial species Amt Det Amt Det 
Bifidobacterium longum 10ng P 10ng A 
Bifidobacterium catenulatum - A - A 
Eggerthella  lenta - A - A 
Bacteroides uniformis 50ng P 50ng P 
Bacteroides ovatus - A - A 
Enterococcus  faecalis - A - A 
Lactobacillus  acidophilus 1ng  P 1ng  P 
Ruminococcus  albus - P - A 
Clostridium  paraputrificum - A - A 
Clostridium  difficile - A - A 
Clostridium  sordellii - A - A 
Clostridium  sphenoides 200ng P 200ng P 
Eubacterium  limosum - A - A 
Holdemania   filiformis - A - A 
Fusobacterium  nucleatum - A - A 
Escherichia  coli - A - A 
Human gDNA - A 3.74µg P 
 
Amt: Amount of gDNA hybridized to chip 
     Det: Detection P- Present/A-Absent/M-Marginal 
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Table 3.4.3.1 summarizes the results of experiments. When amplified 16S rDNA 
was used as target, the microarray could detect even 1ng. So, we wanted to see if the 
microarray can detect even lower amounts when 16S rDNA was used. Due to problems 
with the TAKARA Hot Star DNA polymerase enzyme, all the subsequent amplifications 
were performed using Taq 2X MasterMix PCR reaction mixture from NEB. In order to 
reduce the variability among the experiments, we pooled the bacterial genomic DNA 
with human genomic DNA and carried out the PCR amplifications. Since the amounts of 
starting template are very low, we added gDNA of Holdemania filiformis to be able to 
visualize the amplified product on the agarose gel. In the first experiment, 10pg each of 
Bacteroides uniformis, Lactobacillus acidophilus, Clostridium sphenoides and 
Escherichia coli gDNA were pooled together along with 4.0µg of human gDNA. In 
another experiment, 1pg each of the above four bacterial gDNAs were pooled together 
but no human gDNA was added. In both the experiments, 50ng of Holdemania filiformis 
gDNA was used as a control to be able to visualize the amplified product on a gel. 
Table 3.4.3.2 Detection limit when 10pg and 1pg of amplified 16S rDNA is used 
 
 In presence of 
human gDNA 
No human 
gDNA 
Bacterial species Amt Det Amt Det 
Bacteroides uniformis 10pg P 1pg P 
Lactobacillus acidophilus 10pg P 1pg P 
Clostridium sphenoides 10pg P 1pg P 
Holdemania filiformis 50ng P 50ng P 
Escherichia coli 10pg P 1pg M 
Human gDNA 4.0µg P - A 
 
Amt: Amt: Amount of gDNA hybridized to chip 
     Det: Detection P- Present/A-Absent/M-Marginal 
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From the Table 3.4.3.2, it can be seen that the lowest amounts that could be 
detected by the microarray were 10pg of amplified 16S rDNA in presence of human 
gDNA and 1pg of the PCR-amplified 16S rDNA in absence of human gDNA. 
  
3.5 RNA as starting material 
 The microarray was designed as antisense type which allows both DNA and RNA 
targets to be interrogated and so we wanted to validate the use of total RNA as the 
starting material for hybridization. RNA from five bacterial species, Bacteroides 
uniformis, Lactobacillus acidophilus, Clostridium sphenoides, Bifidobacterium longum 
and Escherichia coli was used. Only these five species were used in particular because 
these are the species from which we had highest yields of total RNA.  
 cDNA synthesis from the RNA mixture was carried out as described in the 
standard Affymetrix GeneChip protocol (Appendix I). The resultant end-product was 
terminally labeled with biotin and hybridized onto the microarrays. Two replicates were 
performed to check for consistency in the detection by the microarray and reproducibility 
of the results. 
Table 3.5.1 RNA as starting material 
 1
st
 replicate 2
nd
 replicate 
Bacterial species Amt Det Amt Det 
Bifidobacterium longum 100ng P 100ng P 
Bacteroides uniformis 100ng P 100ng P 
Lactobacillus acidophilus 100ng P 100ng P 
Clostridium sphenoides 100ng P 100ng P 
Escherichia coli 100ng P 100ng P 
Amt: Amount of gDNA hybridized to chip 
     Det: Detection P- Present/A-Absent/M-Marginal 
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From the above table, it can be seen that all the bacterial species’ RNA has been 
detected and the use of RNA as a starting material for hybridization has been successfully 
tested. Sensitivity of the microarray was even greater when RNA was used as target. 
 
3.6 Fold change experiments 
 Fold change experiments were done to examine if the microarray can detect 
quantitative changes in the composition of the microflora and try to establish a 
relationship between the expected and observed signals. Six bacterial species, 
Bifidobacterium longum, Bacteroides uniformis, Lactobacillus acidophilus, Clostridium 
sphenoides, Holdemania filiformis and Escherichia coli were used. Of these, the first four 
species were used to assess actual fold change experiments and Holdemania filiformis 
was used in constant amount in all the experiments to normalize the signal intensities 
across all the experiments. E.coli gDNA was used in appropriate amounts to adjust the 
total amount of sample hybridized to the chips in each experiment to 1.0µg. 12.5ng to 
200ng of the four bacterial species were used in order to provide a 16-fold difference in 
the amounts hybridized onto the microarray. 
Table 3.6.1 Fold change experiments 
 
 Amounts hybridized onto the microarray 
Bacterial species Expt 1 Expt 2 Expt 3 Expt 4 Expt 5 Expt 6 
Bifidobacterium longum 12.5ng 25ng 50ng 100ng 150ng 200ng 
Bacteroides uniformis 12.5ng 25ng 50ng 100ng 150ng 200ng 
Lactobacillus acidophilus 12.5ng 25ng 50ng 100ng 150ng 200ng 
Clostridium sphenoides 12.5ng 25ng 50ng 100ng 150ng 200ng 
Holdemania filiformis 100ng 100ng 100ng 100ng 100ng 100ng 
Escherichia coli 850ng 800ng 700ng 500ng 300ng 100ng 
Total amount on chip 1.0µg 1.0µg 1.0µg 1.0µg 1.0µg 1.0µg 
 
 47    
 
 For these experiments, 1.5 µg of each of the four bacterial total gDNA was pooled 
together and fragmented. Similarly, 1 µg of gDNA from Holdemania filiformis and 4 µg 
of E.coli gDNA were taken and fragmented separately.  
 
Figure 3.6.1 Relationship between expected signal and actual signal ratios 
 Figure 3.6.1 shows the results of the fold change experiments and the relationship 
between the expected signal ratio and the observed signal ratio. The dots in the graph 
correspond to the averages of the expected signal and observed signal ratios and it can be 
observed that there is a good correspondence between expected and observed signal 
values with the R
2 
(coefficient of determination) value being equal to 0.94 and slope of 
the linear trendline equal to 0.79. It can be seen from the above graph that the observed 
signal ratios deviate from the expected ratios at higher fold changes. This is thought to 
occur because with the increasing fold change the hybridization mixture becomes 
saturated with higher amounts of nucleic acid fragments of the same species.  
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3.7 Microarray analysis of fecal samples 
 To know whether the microarray can identify and quantify the various bacterial 
species present in fecal samples, four fecal samples were obtained from healthy 
volunteers (two adults and two children). DNA was isolated from all the fecal samples 
using QIAamp DNA Stool Mini Kit (Qiagen). PCR amplification of 16S rDNA was 
carried out from all the samples using the Taq 2X MasterMix from NEB. Three 
individual PCR reactions were carried out per each sample so as to reduce the biases, if 
any that might occur during the PCR reaction (Polz et al., 1998). 
The amplified DNA was fragmented with 0.04U/µg of DNase I enzyme. The 
fragmented product was run on a 10% polyacrylamide gel to check the size of the 
fragments obtained. The fragmented DNA was end labeled with biotin and then 
hybridized onto the microarray. Two replicates were done per each sample.  
 
Figure 3.7.1 1% agarose gel of DNA isolated from two adults and two children 
2 µl of each sample is loaded onto gel and A1 and A2 are adult fecal DNAs and C1 and 
C2 are child fecal DNA samples. 
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Table 3.7.1 Bacteria detected by the microarray in fecal samples at Order level 
 
 
 
 
 
 
 
 
 
 
      # Phylo: Number of phylo-species detected for each bacterial class 
      Signal: % contribution to total signal by phylo-species in each bacterial class
 Child 1 Child 2 Adult 1 Adult 2 
Class # Phylo Signal # Phylo Signal # Phylo Signal # Phylo Signal 
Cyanobacteria 0 0.0% 0 0.0% 0 0.0% 1 0.1% 
Alphaproteobacteria 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Betaproteobacteria 4 4.3% 0 0.0% 1 0.1% 1 0.9% 
Gammaproteobacteria 2 2.1% 6 8.3% 0 0.0% 2 0.1% 
Deltaproteobacteria 1 0.3% 1 0.4% 0 0.0% 1 0.3% 
Epsilonproteobacteria 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Clostridia 201 79.0% 192 80.7% 168 90.7% 174 87.3% 
Mollicutes 2 0.0% 3 0.1% 4 0.6% 2 0.1% 
Bacilli 7 1.1% 2 0.1% 2 0.1% 3 0.3% 
Actinobacteria 6 0.1% 0 0.0% 1 0.0% 0 0.0% 
Spirochaetes 0 0.0% 0 0.0% 0 0.0% 1 0.0% 
Bacteroidetes 26 13.0% 33 10.4% 18 7.8% 21 8.9% 
Fusobacteria 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Verrucomicrobiae 1 0.1% 0 0.0% 1 0.7% 1 1.9% 
Lentisphaerae 0 0.0% 1 0.0% 0 0.0% 1 0.0% 
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 The two microarray replicates per each fecal DNA sample had excellent 
correlation among them (Pearson correlation coefficient equal to 0.97, 0.99 respectively 
for the two child fecal samples and 0.99, 0.97 respectively for the two adult samples) 
which indicates excellent reproducibility of the results.  
Analysis of the microarray results showed 238, 250 species were called present in 
the two child fecal samples and 195, 208 species were called present in the two adult 
fecal samples. The above table shows various bacterial classes identified by the 
microarray in the four fecal samples analyzed. All the four fecal samples studied were 
dominated by the members of Clostridia, which is in accordance with the literature that 
Clostridia are the dominant inhabitants of the human intestine. Second highest number of 
species of bacteria present next to Clostridia is Bacteroidetes. Adult fecal samples had 
higher percentages of Clostridia (87-90%) when compared to the children’s samples (79-
81%), whereas the two child samples had higher Bacteroidetes when compared to adult 
samples (10-13% in child samples, 8-9% in adults). Another important difference is that 
children had higher percentages of Proteobacteria when compared to adults (6.7-8.7% in 
children, 0.1-1.3% in adults). However, Verrucomicrobiae were present in adults and not 
in children. Diversity of the bacterial genera detected was quite similar among all the four 
samples- 40 and 43 different genera were detected in child fecal samples, 35-40 genera 
were detected amount the adult samples. Among the child fecal samples, at the order 
level, there were some differences observed. For example, Burkholderiales was present at 
4.3% of the total signal in one child sample, whereas it was completely absent in another 
child sample. The two adult fecal samples had similar compositions at the order level.  
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At the genus level, the most abundant species in the child samples were 
Faecalibacterium, Ruminococcus, and Bacteroides with the contribution being 26, 18, 
and 8% to the total signal, respectively. Among the adult samples studied, the dominant 
species were Ruminococcus, Papillibacter, and Faecalibacterium with 24, 17 and 8% 
(respectively) contribution to the total signal. Roseburia was another genus that is present 
in all the four samples analyzed at a relatively similar level (~7% of total signal).  
 
Table 3.7.2 Bacterial species identified in the fecal samples at Family level 
 
 
Family Adult 1 Adult 2 Child 1 Child 2 
   # Phylo  Signal # Phylo  Signal # Phylo  Signal # Phylo  Signal 
Cyanobacteria - F3.1 0 0.0% 1 0.1% 0 0.0% 0 0.0% 
Rhodobacteraceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Sphingomonadaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Phyllobacteriaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Bradyrhizobiaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Methylobacteriaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Methylocystaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Rhodobiaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Burkholderiaceae 0 0.0% 0 0.0% 1 0.0% 0 0.0% 
Oxalobacteraceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Alcaligenaceae 1 0.1% 1 0.9% 3 4.2% 0 0.0% 
Neisseriaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Xanthomonadaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Moraxellaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Succinivibrionaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Enterobacteriaceae 0 0.0% 2 0.1% 1 0.0% 5 6.9% 
Pasteurellaceae 0 0.0% 0 0.0% 1 2.1% 1 1.4% 
Desulfovibrionaceae 0 0.0% 1 0.3% 1 0.3% 1 0.4% 
Campylobacteraceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Helicobacteraceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Clostridiaceae 63 36.4% 54 26.9% 68 44.0% 54 36.8% 
Lachnospiraceae 64 28.3% 83 44.7% 97 24.4% 100 38.0% 
Peptostreptococcaceae 0 0.0% 0 0.0% 1 0.0% 0 0.0% 
Eubacteriaceae 3 0.2% 5 0.6% 8 2.4% 9 1.7% 
Peptococcaceae 3 1.0% 2 0.2% 0 0.0% 0 0.0% 
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Acidaminococcaceae 35 24.8% 30 14.8% 27 8.1% 27 4.1% 
Thermoanaerobacteriaceae 0 0.0% 0 0.0% 0 0.0% 2 0.1% 
Erysipelotrichaceae 4 0.6% 2 0.1% 2 0.0% 3 0.1% 
Staphylococcaceae 0 0.0% 0 0.0% 1 0.0% 0 0.0% 
Turicibacteraceae 0 0.0% 0 0.0% 1 0.0% 0 0.0% 
Lactobacillaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Enterococcaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Streptococcaceae 2 0.1% 2 0.1% 5 1.0% 1 0.0% 
Firmicutes - IS9 0 0.0% 1 0.2% 0 0.0% 1 0.1% 
Coriobacteriaceae 0 0.0% 0 0.0% 3 0.1% 0 0.0% 
Actinomycetaceae 0 0.0% 0 0.0% 1 0.0% 0 0.0% 
Micrococcaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Dermabacteraceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Corynebacteriaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Bifidobacteriaceae 1 0.0% 0 0.0% 2 0.0% 0 0.0% 
Serpulinaceae 0 0.0% 1 0.0% 0 0.0% 0 0.0% 
Leptospiraceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Bacteroidaceae 11 4.8% 15 7.3% 17 10.8% 25 9.1% 
Rikenellaceae 7 3.0% 6 1.6% 6 2.0% 6 1.2% 
Porphyromonadaceae 0 0.0% 0 0.0% 3 0.2% 2 0.0% 
Prevotellaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Fusobacteriaceae 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Fusobacteria - IS11 0 0.0% 0 0.0% 0 0.0% 0 0.0% 
Verrucomicrobiaceae 1 0.7% 1 1.9% 1 0.1% 0 0.0% 
Victivallaceae 0 0.0% 1 0.0% 0 0.0% 1 0.0% 
 
 At the family level, clear differences between the adult and fecal flora were 
observed. Members of Clostridiaceae and Lachnospiraceae were present at similar levels 
in both adults and children where the members of Acidaminococcaceae were present in 
higher amounts (14.8-18.8%) in adults when compared to children (4.1-8.1%). 
Pasteurellaceae were present in child fecal samples but were not detected in adult fecal 
samples. Bacteroidaceae were present in higher amounts in children (9.1-10.8%) when 
compared to adults (4.8-7.3%).  
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4. Discussion 
 This study describes the validation of a high-throughput, custom-made microarray 
designed to study the human intestinal microflora. It contains probes that can identify and 
quantify the numerous bacterial phylo-species that are believed to reside in the human 
intestine. The validation experiments were carried out using 16 different pure bacterial 
cultures representing various bacterial phylo-species. The microarray correctly identified 
15 out of a total of 16 species. Only Eggerthella lenta was called absent in all the 
validation experiments. The 16S rDNA gene was amplified from Eggerthella lenta and 
DNA sequencing analysis of the fragment showed that the species belonged to genus 
Propionibacterium. The microarray did not contain probes for this bacterium and hence 
could not detect them. Members of Propionibacterium commonly live on skin of humans 
(Brüggemann et al 2004) and are most common contaminants of bacterial cultures due to 
the lack of proper care. Though the experiment turned out to be negative, it represents an 
important validation result because it did not randomly produce signal that might have 
resulted due to incorrect sequence hybridizations.  
 Use of PCR-amplified 16S rDNA led to increased sensitivity of the microarray 
when compared to the use of total genomic DNA because it produced higher signal. 
Cross hybridizations of the target to other probes were low and they have been shown to 
be reduced to significant level by the use of replicates.  
 Other community microarray studies like those performed by Huyghe et al, 2008, 
describe the development and validation of a custom-made community microarray, but 
we believe our study is better in terms of the quality of the validation experiments done. 
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The study by Huyghe et al used only three bacterial species for their validation purposes 
and our study used 16 species and hence is more reliable and accurate. 
  The detection limit of the microarray was 4ng when total genomic DNA was 
used in absence of human gDNA and 1ng when 10 cycles of PCR reaction were carried 
out to amplify the 16S rDNA. When the PCR cycles were increased to 30, as low as 10 
pg of bacterial DNA was detected in presence of human gDNA (represents 0.00025% of 
total sample, which represents 4000-fold dynamic range of detection) and 1pg when no 
human gDNA was used. To ensure that the microarray can quantitatively compare the 
difference in amount of a particular species among different samples, a series of fold 
change experiments have been carried out. A good, close-to-linear correspondence was 
seen between observed and expected signal intensities. 
 The design of microarray was carried out as an antisense type allowing both DNA 
and RNA to be interrogated. The use of DNA as target has been established and probably 
this study is the first to establish that even RNA can be used as a starting material. The 
use of RNA as target led to increased sensitivity of the microarray. 
 Finally, as a test, four fecal samples have been analyzed by the microarray, two 
each from children and adults. The microarray identified several bacterial phylo-species 
from the fecal samples revealing interesting observations. However, Bifidobacteria, 
Lactobacilli, the two genera often used in several probiotic preparations were not 
significantly detected in all four samples. This was thought to be due to the universal 
primers not being efficient in amplifying the members of both genera. For this purpose, a 
modified forward primer Amp_27F_V4 was designed 
(AGRGTTYGATYMTGGCTCAG) which has 4 degenerate positions (the original 
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forward primer, Amp_27F had a single degenerate nucleotide position). PCR on fecal 
sample from one of the child volunteers was carried out with the new forward primers 
(Amp_27F_V4) and the original reverse primer (Univ_1492R) and the product was 
fragmented and hybridized onto microarray. It identified seven different phylo-species of 
Bifidobacteria. But the signal was not high when compared to other members of the 
microflora. This was consistent with the study of Palmer et al, who also showed lower 
amounts of bifidobacteria in adults and children. The detection of Lactobacilli was not 
improved even with the use of new primers indicating absence of species in the samples 
or that they are below the threshold of detection even though they are present.  
 Future work includes the use of this custom microarray to examine clinical 
samples of patients suffering from intestinal disorders like inflammatory bowel disease, 
irritable bowel syndrome, Crohn’s disease and colon cancer to obtain information about 
the composition of the microflora and its changes during diseased condition. The 
information obtained from these studies can help in development of a suitable treatment 
strategy and also decrease chances of mis-diagnosis which happens quite often because of 
the symptom overlap with other common gastro-intestinal ailments.   
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APPENDIX I 
 
Protocol for cDNA synthesis from total RNA 
1. Prepare the following mixture 
 
Components Volume 
Total RNA As required 
75 ng/µl Random primers 10 µl 
Nuclease – free H2O up to 30 µl 
Total Volume 30 µl 
 
2. Incubate the RNA primer mix at the following temperatures 
a. 700C for 10 minutes 
b. 250C for 10 minutes 
c. Chill to 40C 
3. Prepare the following cDNA synthesis reaction mixture 
Components  Volume 
RNA primer hybridization mix from previous step 30 µl 
5X 1
st
 Strand buffer 12 µl 
100mM DTT 6 µl 
10mM dNTPs 3 µl 
SUPERase (20U/ µl) 1.5 µl 
SuperScript II (200U/ µl) 7.5 µl 
Total volume 60 µl 
 
4. Incubate the reaction mixture as follows 
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a. 250C for 10 minutes 
b. 370C for 60 minutes 
c. 420C for 60 minutes 
d. Inactivate SuperScript II at 700C for 10 minutes 
e. Chill to 40C 
5. Remove the RNA by adding 20 µl of 1N NaOH and incubate for 650C for 30 minutes 
followed by addition of 20 µl of 1N HCl to neutralize. 
6. Purify the cDNA by Qiagen MinElute PCR Purification Columns.  
 The resultant cDNA can now be fragmented using 0.6 U/µg of cDNA. The 
fragmented product is now ready to be terminally labeled with biotin in a terminal 
transferase reaction as follows- 
Components Volume 
5X Reaction buffer 10 µl 
GeneChip DNA labeling reagent 2 µl 
Terminal deoxynucleotidyl transferase 2 µl 
Fragmented cDNA product up to 20 µl 
Nuclease-free H2O  16 µl 
Total volume 50 µl 
 
Incubate the above reaction mixture at 37
0
C for 60 minutes. Add 2 µl of 0.5M EDTA 
to stop the labeling reaction. The labeled product is ready to be hybridized onto the 
microarrays. Prepare the hybridization mixture as follows- 
Components Volume 
2X Hybridization buffer 65 µl 
3nM B2 Control oligo 2.2 µl 
10 mg/ml Herring Sperm DNA 1.3 µl 
50 mg/ml BSA 1.3 µl 
100% DMSO 10.2 µl 
Fragmented and labeled cDNA product up to 50 µl 
Molecular biology grade water - 
Total volume 130 µl 
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APPENDIX II 
 
PCR Reaction protocol 
1. 940C for 30 seconds 
2. 980C for 10 seconds 
3. 550C for 15 seconds 
4. 720C for 90 seconds 
5. Repeat Step 2 as per the number of cycles required 
6. 40C for ever 
7. End  
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APPENDIX III 
 
2-log DNA ladder  
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